Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Cs. B. Pénzes"'
Publikováno v:
European Polymer Journal. 49:2495-2503
Biodegradable polylactic/glycolic acid copolymers are widely used as colloidal drug delivery systems. PLGA nanoparticles were prepared using non-ionic, PEO-containing block copolymer (Pluronic) and charged polymeric (PEI) surface modifiers. Physicoch
Publikováno v:
Colloids and Surfaces A: Physicochemical and Engineering Aspects. 413:142-148
a b s t r a c t Surface behaviour of mixed monolayers of DPPC and mycolic acid as a specific membrane component of Mycobacterium tuberculosis were studied by Langmuir-balance technique. Additivity analysis of the surface pressure-area isotherms showe
Publikováno v:
Journal of Dispersion Science and Technology. 32:1728-1734
Isoniazid (INH) is a first line drug for treatment of the widespread deadly disease caused by Mycobacterium tuberculosis. Peptide conjugate of INH was designed and synthesised for targeted and receptor mediated cellular uptake of INH. Chemical compos
Autor:
Tivadar Lohner, Miklós Mohai, Cs. B. Pénzes, Gergő Gyulai, Sándor Kurunczi, Éva Kiss, Peter Petrik
Publikováno v:
Journal of Colloid and Interface Science. 362:600-606
Biodegradable polyesters such as poly(lactic-co-glycolic acid) copolymers (PLGA) are preferred materials for drug carrier systems although their surface hydrophobicity greatly limits their use in controlled drug delivery. PLGA thin films on a solid s
Publikováno v:
Trends in Colloid and Interface Science XXIV ISBN: 9783642190377
Tuberculosis is a major problem throughout the world causing 1.9 million deaths annually, and induces a major global public health problem. The pathogen responsible for the disease is Mycobacterium tuberculosis. Drug candidates expected to be specifi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::54858755f1412da3b5c4ab43233e8c60
https://aperta.ulakbim.gov.tr/record/19709
https://aperta.ulakbim.gov.tr/record/19709
Publikováno v:
Colloids for Nano-and Biotechnology ISBN: 9783540851332
Tuberculosis remains a major problem throughout the world causing large number of deaths, more than that from any other single infectious disease [1]. The treatment of the chronic inflammatory caused by Mycobacterium tuberculosis (Mtb) requires prolo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d1edceed52d68054250216e9a8567ea7
https://doi.org/10.1007/2882_2008_117
https://doi.org/10.1007/2882_2008_117